Braxia Scientific CEO Dr Roger McIntyre and KetaMD CEO Warren Gumpel joined Steve Darling from Proactive to share news the company has announced the launch of KetaMD in Florida.

McIntyre telling Proactive KetaMD has been able to onboarded new patients and completed initial ketamine treatments.
Gumpel told Proactive those patients received medically supervised treatments, guided virtually by registered nurses with mental health expertise, while still staying at home.